Thanks to private funding, 100% of every dollar donated to The Lustgarten Foundation goes directly to pancreatic cancer research.

Pancreatic Cancer Research Consortium

TesttubesThe Lustgarten Foundation has formed a national Pancreatic Cancer Research Consortium (PCRC), representing a unique collaborative effort in the fight against this disease. The Lustgarten Foundation has provided an initial $10 million to launch the PCRC. Over the next several years, The Foundation expects to contribute more than $25 million to the PCRC.

The PCRC is comprised of six world-renowned institutions: Cold Spring Harbor Laboratory, Dana-Farber Cancer Institute in affiliation with Harvard Medical School, Johns Hopkins University School of Medicine, The David H. Koch Institute for Integrative Cancer Research at MIT, Memorial Sloan-Kettering Cancer Center, and The University of Texas M.D. Anderson Cancer Center.  

PCRC: The whole is greater than the sum of its parts

Through the sharing of knowledge, information, expertise and technologies, PCRC members will work together to develop and execute a comprehensive long-term research program to find a cure for the disease. The PCRC will operate on the guiding principle that a cooperative approach to science will produce more effective and more efficient research, and will shorten the road to a cure.

Pancreatic Cancer Research Consortium Listing

Cold Spring Harbor Laboratory

Bruce Stillman, Ph.D.
President, Cold Spring Harbor Laboratory

Dana-Farber Cancer Institute/Harvard Medical School

Charles Fuchs, M.D., M.P.H.
Director, Gastrointestinal Cancer Center, Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School

Robert Mayer, M.D.
Faculty Vice President for Academic Affairs, Dana-Farber Cancer Institute
Stephen B. Kay Family Professor of Medicine, Harvard Medical School

Johns Hopkins University School of Medicine

Ralph Hruban, M.D.
Professor of Pathology and Oncology
Director, The Sol Goldman Pancreatic Cancer Research Center
Johns Hopkins University School of Medicine

Bert Vogelstein, M.D.
Investigator, Howard Hughes Medical Institute
Ludwig Center for Cancer Genetics & Therapeutics
Clayton Professor of Oncology & Pathology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

The Koch Institute for Integrative Cancer Research at MIT

Tyler Jacks, Ph.D.
David H. Koch Professor
Director, Koch Institute for Integrative Cancer Research, Masachusetts Institute of Technology
Investigator, Howard Hughes Medical Institute

Matthew Vander Heiden, M.D., Ph.D.
Assistant Professor, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology

Memorial Sloan-Kettering Cancer Center

David Kelsen, M.D.
Edward S. Gordon Chair in Medical Oncology
Chief, Gastrointestinal Oncology Service
Memorial Sloan-Kettering Cancer Center

Scott Lowe. Ph.D
Chair, Cancer Biology & Genetics Program, SKI; Chair
Geoffrey Beene Cancer Research Center

Eileen O’Reilly, M.D.
Associate Attending Physician, Memorial Sloan-Kettering Cancer Center

The University of Texas M.D. Anderson Cancer Center

James Abbruzzese, M.D.
Chairman, Department of Gastrointestinal Medical Oncology
The University of Texas M.D. Anderson Cancer Center

David McConkey, Ph.D.
Professor, Cancer Biology and Urology
Deputy Division Head for Research, Division of Surgery
Director of Urological Research
The University of Texas M.D. Anderson Cancer Center

415 Crossways Park Drive, Suite D, Woodbury, NY 11797
Toll Free: 1-866-789-1000 P: 516-737-1550 F: 516-584-6265


2015 website development and design sponsored by Celgene